ANW:FRA
Immuron Ltd
€0.020
0.00%
(0.00) 1D
Oct 9, 8:03:28 AM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ANW...
Open
€0.02
High
€0.02
Low
€0.02
Mkt. cap
10.33M
Avg. vol.
627.00
Volume
0.00
52-wk high
€0.04
52-wk low
€0.01
No. of employees
8
Open
€0.02
High
€0.02
Low
€0.02
Mkt. cap
10.33M
Avg. vol.
627.00
Volume
0.00
52-wk high
€0.04
52-wk low
€0.01
No. of employees
8
News stories
From web sources and news partners
Advisor Perspectives
·
16 minutes ago
AI Powered Bull Market in S&P, Now It Needs More Building Blocks
24/7 Wall St.
·
12 minutes ago
Stock Market Today: Tech Leads Stocks Toward a Higher Open as Treasury Yields Ease
ChartMill
·
1 hour ago
Get insights into the top movers in the S&P500 index of Friday's pre-market session.
VT Markets
·
3 hours ago
Dow Jones (DJ30) Climbs: US Futures Recover from AI Stock Selloff
Profile
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
About Immuron Ltd
CEO-
Employees8
Founded1994
HeadquartersBlackburn North, Victoria, Australia
SectorBiotechnology
Websiteimmuron.com.au